March 2015

Erratum

In the MIMS January update, the published recommended age for the use of Nasonex Allergy Aqueous Nasal Spray (mometasone furoate monohydrate) was incorrect. The correct recommended age is as follows.

Nasonex Allergy Aqueous Nasal Spray (mometasone furoate monohydrate) is indicated for the treatment of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and prophylaxis of seasonal allergic rhinitis for up to 6 months in adults and children 12 years of age and older.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au